The clinical presentation of pulmonary embolism (PE) varies widely, ranging from only limited symptoms to severe cardiogenic shock. Treatment of PE comprises initial therapy—with low-molecular-weight ...

Pulmonary embolism (PE) is caused by emboli, which have originated from venous thrombi, travelling to and occluding the arteries of the lung. PE is the most dangerous form of venous thromboembolism, ...

ACUTE pulmonary embolism occurs frequently, but its diagnosis is difficult. Its recognition in practice depends largely upon the signs and symptoms of infarction rather than the presence of pulmonary ...

Patients with intermediate-high risk pulmonary embolism have an elevated right-to-left ventricular diameter ratio and are at ...

The European Society of Cardiology (ESC) Guidelines on acute pulmonary embolism are published online today in European Heart Journal, and on the ESC website. They were developed in collaboration with ...

In 15 patients with definite angiographic evidence of embolism involving both lungs, and treated with heparin or venous ligation or both, sequential studies showed only minimal angiographic and ...

Pulmonary Circulation, Vol. 5, No. 3 (September 2015), pp. 577-579 (3 pages) 1. Roberts KE, Hamele-Bena D, Saqi A, Stein CA, Cole RP. Pulmonary tumor embolism: a ...

In a recent study published in Thrombosis Research, researchers determined plasma signatures of proteins related to or derived from platelets in acute isolated pulmonary embolism (iPE) and deep vein ...

Please provide your email address to receive an email when new articles are posted on . The retrospective cohort study included 61,070 adults (mean age, 61.6 years; 52.5% women) with newly diagnosed ...

Before it began making use of artificial intelligence applications, Jefferson Einstein, part of the Jefferson Health system, faced a growing challenge in managing acute pulmonary embolism cases.

EKOS Corporation, a BTG International group company (BTG plc (LSE: BTG)), notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63 rd Annual Scientific Session ...